Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification and validation of obesity related genes signature based on microenvironment phenotypes in prostate adenocarcinoma.

Aging - 2 Oct 2023

Liang Linghui, Shang Jinwei, Zhang Yuwei, Xu Yuxin, Zhouteng Yihui, Wen Jianxiang, Zhao Yuxin, Feng Ninghan, Zhao Ruizhe

Abstract excerpt

BACKGROUND: The role of obesity related genes (ORGs) in the immune checkpoint inhibitors (ICIs) treatment of prostate adenocarcinoma (PRAD) has not yet been proved by research. METHODS: We comprehensively evaluated the ORGs patterns in PRAD based on tumor microenvironment (TME) phenotypes and immunotherapy efficacies. Then we constructed a ORGs risk score for prognosis and a ORGs signature for accurate prediction...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Obesity

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Phenotype

Share to Prognosis

Share to Prostate

Share to Prostatic Neoplasms

Share to Risk Factors

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 37788005
DOI: 10.18632/aging.205065
PMCID: PMC10599753

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and validation of obesity related genes signature based on microenvironment phenotypes in prostate adenocarcinoma.PMID 37788005Read ↗

Identification and validation of obesity related genes signature based on microenvironment phenotypes in prostate adenocarcinomSemantic proximity Read ↗

Identification and validation of the pyroptosis-related genes signature based on immune microenvironment and molecular heterogeneity in prostate adenocarcinomaSemantic proximity Read ↗

Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer.Semantic proximity Read ↗

The Analysis of Tumor Microenvironment of Prostate Cancer Identifies Prognostic SignaturesSemantic proximity Read ↗

Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the Cancer Gene AtlasSemantic proximity Read ↗

Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapySemantic proximity Read ↗

Establishing a Prognostic Model in Prostate Adenocarcinoma through Comprehensive scRNA-Seq and Bulk RNA-Seq Analysis and ValidationSemantic proximity Read ↗

Predicting Prostate Adenocarcinoma Patients’ Survival and Immune Signature: A Novel Risk Model Based on Telomere-Related GenesSemantic proximity Read ↗

A Risk Score Model Associated with Tumor Microenvironment Predicts Disease-Free Survival After Radical ProstatectomySemantic proximity Read ↗

Network Models of Prostate Cancer Immune Microenvironments Identify ROMO1 as Heterogeneity and Prognostic MarkerSemantic proximity Read ↗

Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications.Semantic proximity Read ↗

Identification of Prostate Cancer Subtypes Based on Immune Signature Scores in Bulk and Single Cell TranscriptomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.